Immunotherapy Master Trial for Advanced Cancers

NCT07431073 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

275

Enrollment

OTHER

Sponsor class

Conditions

Advanced / Metastatic Solid Tumors
Advanced Malignancy

Interventions

DRUG: METAREM is a master protocol that encompasses multiple therapeutic sub-protocols, each involving distinct interventions. Accordingly, the description of the intervention will be specified within each

Sponsor

UNICANCER